Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects

Journal of Infectious Diseases

Volumn 200, Issue 2, 2009, Pages 191-201

  Liu, Ping ^a,b   Woda, Mareia ^b   Ennis, Francis A ^b   Libraty, Daniel H ^b  

^a GENZYME CORPORATION   (United States)

^b UMMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; INTERFERON; TUMOR NECROSIS FACTOR;

ANGIOGENESIS; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CULICIDAE; DENGUE VIRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE I; MICROARRAY ANALYSIS; RNA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67650694076     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/599795     Document Type: Article

References (50)

1. Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev 1990; 3: 376-96.
2. Pinheiro FP, Corber SJ. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat Q 1997; 50:161-9.
3. Dewi BE, Takasaki T, Kurane I. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J Virol Methods 2004; 121:171-80.
4. Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol 2004; 85:1801-13.
5. Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004; 189:1411-8.
6. Gubler DJ, Zaki SR. Dengue and other viral hemorrhagic fevers. In: Nelson AM, Horsburgh CR Jr, eds. Pathology of emerging infections. Vol 2. Washington, DC: American Society for Microbiology, 1998: 43-67.
7. Rothman AL, Ennis FA. Immunopathogenesis of dengue hemorrhagic fever. Virology 1999; 257:1-6.
8. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: World Health Organization, 1997.
9. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006; 86:279-367.
10. Libraty DH, Endy TP, Houng HS, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002; 185:1213-21.
11. Green S, Vaughn DW, Kalayanarooj S, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999; 179:755-62.
12. Sosothikul D, Seksarn P, Pongsewalak S, Thisyakom U, Lusher J. Activation of endothelial cells, coagulation and fibrinolysis in children with dengue virus infection. Thromb Haemost 2007;97:627-34.
13. Luplertlop N, Misse D, Bray D, et al. Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep 2006;7:1176-81.
14. Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol 2001; 75:3501-8.
15. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420:885-91.
16. Hunt NH, Golenser J, Chan-Ling T, et al. Immunopathogenesis of cerebral malaria. Int J Parasitol 2006; 36:569-82.
17. Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 2007; 117:1119-27.
18. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007; 117:1175-83.
19. Shaw SK, Bamba PS, Perkins BN, Luscinskas FW Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium. J Immunol 2001; 167:2323-30.
20. Warke RV, Xhaja K, Martin KJ, et al. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol 2003; 77:11822-32.
21. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4:249-64.
22. Indraccolo S, Pfeffer U, Minuzzo S, et al. Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol 2007; 178: 1122-35.
23. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4:P3.
24. Fernandez-Sesma A, Marukian S, Ebersole BJ, et al. Influenza virus evades innate and adaptive immunity via the NS 1 protein. J Virol 2006;80: 6295-304.
25. Kislauskis EH, Zhu X, Singer RH. Beta-actin messenger RNA localization and protein synthesis augment cell motility. J Cell Biol 1997; 136:1263-70.
26. Tracey KJ, Vlassara H, Cerami A. Cachectin/tumour necrosis factor. Lancet 1989; 1:1122-6.
27. Colamonici OR, Domanski P, Sweitzer SM, Larner A, Buller RM. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J Biol Chem 1995; 270:15974-8.
28. Qin G, Kishore R, Dolan CM, et al. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proc Natl Acad Sci U S A 2006; 103:11015-20.
29. Verin AD, Birukova A, Wang P, et al. Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation. Am J Physiol Lung Cell Mol Physiol 2001; 281:L565-74.
30. Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 1989; 169:1977-91.
31. Hirschberg RM, Sachtleben M, Plendl J. Electron microscopy of cultured angiogenic endothelial cells. Microsc Res Tech 2005; 67:248-59.
32. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G. H. A. Clowes memorial award lecture. Cancer Res 1986; 46:467-73.
33. Risau W. Mechanisms of angiogenesis. Nature 1997; 386:671-4.
34. Fainaru O, Adini I, Benny O, et al. Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J 2008; 22:3728-35.
35. Ryan GB, Majno G. Acute inflammation: a review. Am J Pathol 1977;86: 183-276.
36. Balsitis SJ, Coloma J, Castro G, et al. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg 2009; 80:416-24.
37. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol 2006; 7:131-7.
38. Mori M, Rothman AL, Kurane I, et al. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 1999; 179:295-302.
39. Borges AA, Campos GM, Moreli ML, et al. Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. Microbes Infect 2006; 8:2324-30.
40. Minagar A, Long A, Ma T, et al. Interferon (IFN)-beta la and IFNbeta lb block IFN-gamma-induced disintegration of endothelial junction integrity and barrier. Endothelium 2003; 10:299-307.
41. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 2003; 100:14333-8.
42. Rath PC, Aggarwal BB. Antiproliferative effects of IFN-alpha correlate with the downregulation of nuclear factor-kappa B in human Burkitt lymphoma Daudi cells. J Interferon Cytokine Res 2001; 21:523-8.
43. Sidky YA, Borden EC. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 1987; 47:5155-61.
44. Nooteboom A, Hendriks T, Otteholler I, van der Linden CJ. Permeability characteristics of human endothelial monolayers seeded on different extracellular matrix proteins. Mediators Inflamm 2000; 9:235-41.
45. Ribatti D, Nico B, Vacca A, Roncali L, Dammacco F. Endothelial cell heterogeneity and organ specificity. J Hematother Stem Cell Res 2002; 11:81-90.
46. Renkonen J, Tynninen O, Hayry P, Paavonen T, Renkonen R. Glycosylation might provide endothelial zip codes for organ-specific leukocyte traffic into inflammatory sites. Am J Pathol 2002; 161:543-50.
47. Harhaj NS, Antonetti DA. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 2004; 36: 1206-37.
48. Majno G, Palade GE. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol 1961; 11:571-605.
49. Halstead SB. Dengue. Lancet 2007; 370:1644-52.
50. Ajariyakhajorn C, Mammen MP Jr, Endy TP, et al. Randomized, placebo-controlled trial of nonpegylated and pegylated forms of recombinant human alpha interferon 2a for suppression of dengue virus viremia in rhesus monkeys. Antimicrob Agents Chemother 2005; 49: 4508-14.